Immunological modifications following chemotherapy are associated with delayed recurrence of ovarian cancer.
Adzibolosu N, Alvero AB, Ali-Fehmi R, Gogoi R, Corey L, Tedja R, Chehade H, Gogoi V, Morris R, Anderson M, Vitko J, Lam C, Craig DB, Draghici S, Rutherford T, Mor G.
Adzibolosu N, et al. Among authors: craig db.
Front Immunol. 2023 Jun 26;14:1204148. doi: 10.3389/fimmu.2023.1204148. eCollection 2023.
Front Immunol. 2023.
PMID: 37435088
Free PMC article.